Delivery Order SPE2DB22D1202-SPE2DB25FVMK7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count) with a ceiling value of $1,274.82. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, carries no set-aside designation and represents a competitively awarded transaction. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count packaging) with a ceiling value of $12,838.18. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 16, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract represents a discrete...
- The Defense Logistics Agency awarded a $2,854.29 delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of April 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) valued at $1,603.56. This firm fixed-price delivery order is scheduled for completion by September 22, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,966.33 for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on August 7, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.24 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a single delivery order issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count containers) with a ceiling value of $1,339.92. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVMK7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for dextroamphetamine-amphetamine 20 mg capsules (100-count) with a ceiling value of $1,688.06. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for ultimate completion on September 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution center for federal medical procurement operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial potential value of $999,999,999.00 through December 2026. As a prime pharmaceutical vendor under this comprehensive global contract vehicle, AmerisourceBergen supplies a wide range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. The company's federal contracting portfolio demonstrates consistent capability in delivering controlled pharmaceutical substances, specialty medications, and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/25/25 |